Suggested for -nE:
FCARP - Overview: Cancer-Associated Retinopathy Panel (CARP) by Immunoblot and IHC
Cancer-Associated Retinopathy Panel (CARP) by Immunoblot and IHC
CHIKS - Overview: Chikungunya Virus, PCR, Molecular Detection, Serum
Qualitative detection of chikungunya virus in serum after early symptom onset (ideally <7 days) This test is not recommended for screening healthy patients.
CEE52 - Overview: CD52 Cell Expression Evaluation, Varies
Detecting cell-surface antigens on malignant cells that are potential therapeutic antibody targets, specifically CD52 Determining the eligibility of patients for monoclonal antibody therapies Monitoring response to the therapeutic...
SFIG - Overview: Cerebrospinal Fluid IgG Index Profile, Serum and Spinal Fluid
Aiding in the diagnosis of multiple sclerosis and other central nervous system inflammatory conditions
CHF8P - Overview: Chromogenic Factor VIII Inhibitor Bethesda Profile, Plasma
Detecting the presence and titer of a specific factor inhibitor directed against coagulation factor VIII for patients on emicizumab (Hemlibra) Detecting the presence and titer of an inhibitor directed against factor VIII This test is not...
CFMP - Overview: Cystic Fibrosis, CFTR Gene, Variant Panel, Varies
Confirmation of a clinical diagnosis of cystic fibrosis Reproductive risk refinement via carrier screening for individuals in the general population Reproductive risk refinement via carrier screening for individuals with a family history...
FCUKG - Overview: Cucumber IgG
Cucumber IgG
CATP - Overview: Catecholamine Fractionation, Free, Plasma
Diagnosing pheochromocytoma and paraganglioma, as an auxiliary test to fractionated plasma and urine metanephrine measurements Diagnosis follow-up of patients with neuroblastoma and related tumors, as an auxiliary test to urine...
3A5Q - Overview: Cytochrome P450 3A5 Genotype, Varies
Aids in optimizing treatment with tacrolimus and other drugs metabolized by cytochrome P450 3A5
HSCRP - Overview: C-Reactive Protein, High Sensitivity, Serum
Assessment of risk of developing myocardial infarction in patients presenting with acute coronary syndromes Assessment of risk of developing cardiovascular disease or ischemic events in individuals who do not manifest disease at present